MIT Develops Implantable Device for Improved Glioblastoma Drug Delivery

MIT researchers have created an implantable drug-delivery device designed to prevent glioblastoma recurrence. This device features a drug reservoir for sustained release and uses ultrasound transducers to help drugs cross the blood-brain barrier and spread more effectively. This innovation could significantly improve treatment outcomes for aggressive brain tumors by enhancing drug penetration and reducing recurrence rates.